Försäljningsutvecklingen av stark i kvartalet och en bredare marknad öppnar sig för bolaget.
On the 14h of December 2022, Brain+ A/S (“Brain+” or the ”Company”) announced that the Company has s...
Ngenic is receiving orders and entering into new partnerships at a rapid pace.
Redeye updates its fair value range following the up to 53 design wins from a new major North Americ...
Seizes the opportunity to buy media assets from CTM Following Catena Media's strategic review, which...
EBIT guidance 17% below cons. for Q4'22e The previous FY'22 adj.
FY'22 oper. EBITA likely negative, implies EUR -2.2m in Q4 Eltel announced a profit warning recently...
Biovica has secured the SEK 140m new funds in growth capital and the US commercial team is also in p...
Ultimovacs has announced the completion of patient enrollment in the Phase I TENDU study in prostate...
Det femåriga avtalet med Stena Recycling innebär att CirChem täcker nära 80 % av den kapacitet som a...
Redeye thinks the cost cutting program underlines the uncertain economic environment while reducing ...
Redeye comments on Mendus presenting ADVANCE II survival data at ASH 2022.
Redeye updates its view on Media and Games Invest following its Q3 2022 report.
Fluicell offers innovative R&D instruments for single-cell analysis and 3D bioprinting, a business a...
Transfer är en säkerhetskoncern vilka tillhandahåller en plattform för bolag att skala upp, dela på ...
Redeye comments on the positive results in the phase IIb melanoma trial with Moderna’s and Merck’s m...
Licensavtal i Japan Calliditas meddelade under gårdagen att de tecknat ett licensavtal med Viatris f...
Mangold uppdaterar investmentbolaget Capsek. Sju av Capseks onoterade portföljbolag som är i en tidi...
Investmentbolaget Archelon investerar främst i prospekteringsbolag inom gruvnäring, men innehar även...
Macro indicators starting to turn in favour of Midsona'23e-'24e EBIT up 7-4%Trading at '23e EV/EBITA...
